Drug:
Reaction: INFECTION
20250101 - 20251231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 25108805 |
GB |
2 | |
Infection, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 202 | 25108853 |
US |
37 | 2 |
Infection, Asthma, |
||||
DUPILUMAB, |
||||
| 203 | 25109071 |
FR |
66 | 2 |
Pyelonephritis, Infection, |
||||
NAPROXEN, NAPROXEN SODIUM, ALPRAZOLAM, ALPRAZOLAM, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, FLUOXETINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CAPSULES, |
||||
| 204 | 25102465 |
US |
1 | |
Shoulder operation, Infection, |
||||
UPADACITINIB, |
||||
| 205 | 25102583 |
US |
2 | |
Infection, Intestinal obstruction, |
||||
UPADACITINIB, |
||||
| 206 | 25102751 |
US |
||
Drug ineffective, Infection, Memory impairment, Intentional product misuse, Product use issue, Device delivery system issue, Incorrect dose administered by device, Emergency care, Cough, Personality disorder, Illness, Fatigue, Product dose omission issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 207 | 25103119 |
US |
59 | 2 |
Nausea, Vomiting, Infection, |
||||
ABATACEPT, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 208 | 25103408 |
GB |
2 | |
Flail chest, Balance disorder, Productive cough, Dyspnoea, Dyspnoea, Hyponatraemia, Effusion, Respiratory failure, Muscular weakness, Fall, Chronic obstructive pulmonary disease, Rhinorrhoea, Hypervolaemia, Infection, |
||||
RISANKIZUMAB-RZAA, ALBUTEROL SULFATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BUMETANIDE, MOMETASONE, BETAMETHASONE DIPROPIONATE, AMLODIPINE, LOSARTAN, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOPIDOGREL, CLOPIDOGREL BISULFATE, AMOXICILLIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, SENNOSIDES, SENNA LEAF, SENNA, SENNOSIDES 8.6 MG TABLETS, OXYCODONE, ALBUTEROL SULFATE, ALBUTEROL, FUROSEMIDE, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, LANSOPRAZOLE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 209 | 25103443 |
IT |
||
Haematological malignancy, Cataract, Neutropenia, Pneumonia, Neoplasm, Peripheral sensory neuropathy, Diarrhoea, Upper respiratory tract infection, Infection, |
||||
LENALIDOMIDE, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 210 | 25103474 |
AR |
60 | 2 |
Mental impairment, Animal bite, Pain, Fatigue, Infection, Tendonitis, Movement disorder, Wound infection, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, ZOLEDRONIC ACID, |
||||
| 211 | 25103508 |
IN |
||
Infection, COVID-19, Urinary tract infection, Cytomegalovirus infection, BK virus infection, Mucormycosis, Dengue fever, Thrombocytopenia, Leukopenia, |
||||
RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ANTI-THYMOCYTE GLOBULIN (RABBIT), BASILIXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 212 | 25104345 |
US |
31 | 1 |
Infection, Febrile neutropenia, Myelosuppression, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, |
||||
| 213 | 25104347 |
US |
75 | 2 |
Febrile neutropenia, Myelosuppression, Infection, Drug ineffective, Disease progression, Off label use, |
||||
ETOPOSIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, CARBOPLATIN, THIOTEPA, |
||||
| 214 | 25104462 |
CA |
40 | 2 |
Uterine operation, Uterine leiomyoma, Infection, Oral infection, Pyrexia, Oropharyngeal pain, Intentional dose omission, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, AMOXICILLIN, |
||||
| 215 | 25104621 |
US |
63 | 1 |
Diarrhoea, Ophthalmic migraine, Blood phosphorus decreased, Nasal dryness, Blood potassium decreased, Therapy interrupted, Intentional underdose, Fatigue, Inappropriate schedule of product administration, Paranasal sinus hyposecretion, Dry mouth, Dry skin, Weight increased, Trigger finger, Tendon pain, Nausea, Tendonitis, Stomatitis, Ear infection, Hyperphagia, Infection, Impaired healing, |
||||
TAMOXIFEN CITRATE, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, NIROGACESTAT, LOSARTAN, |
||||
| 216 | 25104662 |
US |
119 | 1 |
Sepsis, Infection, Febrile neutropenia, Myelosuppression, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, |
||||
| 217 | 25104816 |
US |
61 | 2 |
Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Therapy partial responder, Infection, Cytopenia, |
||||
RITUXIMAB, PREDNISONE, FLUDARABINE PHOSPHATE, ALEMTUZUMAB, IBRUTINIB, OFATUMUMAB, OBINUTUZUMAB, VINCRISTINE SULFATE, VENETOCLAX, |
||||
| 218 | 25104893 |
FR |
67 | 1 |
Infection, Fournier^s gangrene, |
||||
KETOPROFEN, |
||||
| 219 | 25105131 |
US |
1 | |
Visual impairment, Infection, |
||||
NATALIZUMAB, |
||||
| 220 | 25105872 |
US |
2 | |
Vocal cord dysfunction, Infection, Headache, Illness, Vocal cord paresis, Condition aggravated, |
||||
| 221 | 25105892 |
DE |
75 | 2 |
Infection, On and off phenomenon, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 222 | 25105939 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Exostosis, Fatigue, Fibromyalgia, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Red blood cell sedimentation rate increased, Rheumatic fever, Road traffic accident, Sciatica, Seronegative arthritis, Sleep disorder, Sleep disorder due to a general medical condition, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Tachycardia, Type 2 diabetes mellitus, Urticaria, Visual impairment, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, Walking aid user, Spinal fusion surgery, Hip arthroplasty, Crohn^s disease, Rheumatoid arthritis, Rheumatoid factor positive, Retinitis, Bronchitis, Laryngitis, Ear infection, Nasopharyngitis, Sinusitis, Folliculitis, Upper respiratory tract infection, Infection, Helicobacter infection, Pneumonia, Wound infection, Breast cancer stage III, Prescribed underdose, Prescribed overdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, CALCIUM CARBONATE, CALCIUM GLUCONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, TOFACITINIB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 223 | 25106125 |
CA |
59 | 2 |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthritis, Bone erosion, C-reactive protein increased, Condition aggravated, Contraindicated product administered, Crohn^s disease, Decreased appetite, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Ear infection, Exostosis, Maternal exposure during pregnancy, Fatigue, Foot deformity, General physical health deterioration, Glossodynia, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hypersensitivity, Hypoaesthesia, Incorrect route of product administration, Infection, Infusion related reaction, Joint dislocation, Joint stiffness, Joint swelling, Laryngitis, Lupus-like syndrome, Malaise, Mobility decreased, Musculoskeletal stiffness, Nausea, Oedema peripheral, Off label use, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Pneumonia, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatoid arthritis, Rheumatoid factor positive, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapeutic product effect incomplete, Treatment failure, Visual impairment, Wound, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, BUPROPION HYDROCHLORIDE, BUPROPION, DICLOFENAC, DICLOFENAC SODIUM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, BUPROPION HYDROCHLORIDE, TOFACITINIB, SULFASALAZINE, |
||||
| 224 | 25106494 |
US |
25 | 2 |
Infection, |
||||
LEVONORGESTREL, |
||||
| 225 | 25106575 |
DE |
||
Heavy menstrual bleeding, Pneumonitis, Deafness, Drug interaction, Depression, Epstein-Barr virus infection, Asthma, Pain in extremity, Arthralgia, Eructation, Endocrine disorder, Parosmia, Post-acute COVID-19 syndrome, Ear inflammation, Temperature intolerance, Withdrawal syndrome, Smoke sensitivity, Inflammation, Viral infection, Drug intolerance, Sensitivity to weather change, Premenstrual syndrome, Infection, Painful respiration, Hormone level abnormal, Nasal inflammation, Product dose omission in error, Drug ineffective, |
||||
FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, ALBUTEROL, HYDROCORTISONE, |
||||
| 226 | 25106771 |
US |
2 | |
Infection, |
||||
DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 227 | 25106919 |
US |
63 | 2 |
Creatinine renal clearance decreased, Infection, |
||||
CLADRIBINE, |
||||
| 228 | 25106925 |
US |
56 | 2 |
Infection, Dizziness, Dehydration, Vomiting, |
||||
GOLIMUMAB, |
||||
| 229 | 25106943 |
US |
12 | 2 |
Infection, |
||||
TOBRAMYCIN, DORNASE ALFA, TOBRAMYCIN SULFATE, AMOXICILLIN, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, PANCRELIPASE, |
||||
| 230 | 25106992 |
CA |
44 | 2 |
General physical health deterioration, Glossodynia, Grip strength, Grip strength decreased, Hand deformity, Headache, Hepatic cirrhosis, Hypertension, Hypersensitivity, Hypercholesterolaemia, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Lip dry, Liver disorder, Liver injury, Lung disorder, Lupus vulgaris, Lupus-like syndrome, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pancreatitis, Helicobacter infection, Infection, Laryngitis, Nasopharyngitis, Lower respiratory tract infection, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 231 | 25107048 |
ES |
||
Atrial fibrillation, Rash, Infection, Diarrhoea, Hospitalisation, Intentional product use issue, Epistaxis, |
||||
IBRUTINIB, VENETOCLAX, |
||||
| 232 | 25107213 |
US |
55 | 2 |
Nausea, Infection, |
||||
ALBUTEROL SULFATE, AMLODIPINE BESYLATE, LEVOCETIRIZINE DIHYDROCHLORIDE, FLUTICASONE PROPIONATE, OLMESARTAN MEDOXOMIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, DICLOFENAC SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METHOTREXATE SODIUM, FOLIC ACID, PREDNISONE, ALBUTEROL SULFATE, TRAMADOL HYDROCHLORIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, |
||||
| 233 | 25107409 |
US |
56 | 2 |
Infection, |
||||
| 234 | 25107523 |
US |
78 | 1 |
Acute myeloid leukaemia recurrent, COVID-19, Infection, Contusion, Therapeutic product effect decreased, Stress, |
||||
VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE, AZACITIDINE, |
||||
| 235 | 25112445 |
78 | 2 | |
Pyrexia, Fatigue, Pain in extremity, Gait disturbance, Blood sodium decreased, Blood magnesium decreased, Hypertransaminasaemia, Neutrophil count decreased, Nephrolithiasis, Hepatocellular injury, Infection, Hepatic ischaemia, Drug reaction with eosinophilia and systemic symptoms, Drug-induced liver injury, Immune-mediated hepatic disorder, Therapy interrupted, |
||||
TECLISTAMAB, |
||||
| 236 | 25113354 |
64 | 2 | |
Therapy interrupted, Infection, |
||||
ADALIMUMAB, |
||||
| 237 | 25097253 |
US |
63 | 2 |
Pulmonary congestion, Pyrexia, Cough, Ear pain, Infection, |
||||
DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT), POMALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 238 | 25097769 |
US |
2 | |
Nephrolithiasis, Impaired gastric emptying, Infection, Orthostatic hypertension, Osteoporosis, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 239 | 25098034 |
CH |
22 | 2 |
Hyperkalaemia, Diabetic metabolic decompensation, Diabetic ketoacidosis, Drug dose omission by device, Vomiting, Infection, Diarrhoea, COVID-19, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 240 | 25098203 |
CA |
62 | |
Cough, Erythema, Breath sounds abnormal, Bronchial obstruction, Dyspnoea, Infection, Pyrexia, Sleep disorder due to a general medical condition, Sputum discoloured, Temperature intolerance, Wheezing, Product dose omission issue, Drug ineffective, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, PREDNISONE, |
||||
| 241 | 25098668 |
US |
66 | 2 |
Infection, |
||||
ELAFIBRANOR, |
||||
| 242 | 25099014 |
GB |
1 | |
Death, Prostate cancer, Sepsis, Infection, |
||||
CLOZAPINE, |
||||
| 243 | 25099167 |
US |
53 | 2 |
Septic shock, Sepsis, Myelosuppression, Febrile neutropenia, Infection, Off label use, |
||||
ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, |
||||
| 244 | 25099168 |
US |
210 | 1 |
Myelosuppression, Febrile neutropenia, Infection, Off label use, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, TEMOZOLOMIDE, TEMOZOLOMIDE, TEMOZOLOMIDE, TEMOZOLOMIDE, |
||||
| 245 | 25099264 |
CA |
2 | |
Infection, |
||||
TOCILIZUMAB, BISOPROLOL FUMARATE, CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE, PREDNISONE, RAMIPRIL, RISEDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SAXAGLIPTIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN A, ERGOCALCIFEROL, |
||||
| 246 | 25099356 |
ZA |
2 | |
Infection, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, |
||||
| 247 | 25099745 |
US |
61 | 2 |
Infection, |
||||
APREMILAST, |
||||
| 248 | 25099792 |
US |
17 | 2 |
Cardiac arrest, Lung assist device therapy, COVID-19, Peripheral ischaemia, Renal failure, Infection, Malaise, Fall, |
||||
REMDESIVIR, |
||||
| 249 | 25100070 |
US |
1 | |
Infection, |
||||
| 250 | 25100153 |
CA |
2 | |
Abdominal discomfort, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthropathy, Blister, Condition aggravated, Confusional state, Contusion, Discomfort, Duodenal ulcer perforation, Dyspnoea, Folliculitis, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Pericarditis, Rheumatoid arthritis, Systemic lupus erythematosus, Gastrointestinal disorder, Arthralgia, Hepatic enzyme increased, Fatigue, Hypersensitivity, Pain, Pemphigus, Maternal exposure during pregnancy, Contraindicated product administered, Product use issue, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, ETANERCEPT, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, GOLIMUMAB, TOCILIZUMAB, |
||||
| 251 | 25100169 |
FR |
66 | 2 |
Pyelonephritis, Infection, |
||||
NAPROXEN, NAPROXEN SODIUM, FLUOXETINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE, CLOMIPRAMINE HYDROCHLORIDE CAPSULES, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, ALPRAZOLAM, ALPRAZOLAM, |
||||
| 252 | 25100304 |
US |
48 | 2 |
Visual impairment, Dizziness, Infection, |
||||
ABEMACICLIB, ABEMACICLIB, |
||||
| 253 | 25100378 |
US |
||
Immunodeficiency, Psoriatic arthropathy, Sinusitis, Ear infection, Bronchitis, Hypersensitivity, Asthma, Depression, Infection, |
||||
BENRALIZUMAB, |
||||
| 254 | 25100436 |
CA |
77 | 1 |
Buttock injury, Abscess limb, Infection, Inflammation, |
||||
ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, |
||||
| 255 | 25100501 |
CA |
2 | |
General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CALCIUM CARBONATE, VITAMIN C, DICLOFENAC SODIUM, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, LORAZEPAM, CAFFEINE CITRATE, |
||||
| 256 | 25100611 |
GB |
67 | 2 |
Malaise, Vasculitis, Rheumatoid arthritis, Pain, Bone pain, Nasopharyngitis, Tooth fracture, Infection, Cellulitis, Ischaemic skin ulcer, Drug ineffective, Rheumatoid arthritis, Cellulitis, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, HYDROXYCHLOROQUINE, |
||||
| 257 | 25100655 |
JP |
65 | 2 |
Pyoderma gangrenosum, Hypothyroidism, Palmar-plantar erythrodysaesthesia syndrome, Infection, Liver disorder, Platelet count decreased, |
||||
PEMBROLIZUMAB, |
||||
| 258 | 25100705 |
PT |
1 | |
Depressed level of consciousness, Infection, Swelling face, Condition aggravated, Rash erythematous, Pruritus, Malaise, |
||||
ENZALUTAMIDE, |
||||
| 259 | 25100788 |
US |
2 | |
Infection, |
||||
PANCRELIPASE, |
||||
| 260 | 25101123 |
US |
||
Death, Acute myeloid leukaemia, Follicular lymphoma, Mantle cell lymphoma, Diffuse large B-cell lymphoma, Neurotoxicity, COVID-19, Infection, Cardiac disorder, Respiratory failure, Haemorrhagic stroke, Septic shock, Multiple organ dysfunction syndrome, COVID-19 pneumonia, Immune effector cell-associated neurotoxicity syndrome, Atrial fibrillation, Urinary tract infection, Febrile neutropenia, Orthostatic hypotension, Cytokine release syndrome, Diarrhoea, Physical deconditioning, Unevaluable event, Failure to thrive, Cytopenia, Fungal infection, Bacterial infection, Viral infection, |
||||
RITUXIMAB, FILGRASTIM, |
||||
| 261 | 25101168 |
GR |
||
Septic shock, Infection, |
||||
MOGAMULIZUMAB-KPKC, |
||||
| 262 | 25101204 |
CA |
2 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bronchitis, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Ear infection, Exostosis, Fatigue, Fibromyalgia, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Impaired healing, Infection, Infusion related reaction, Injury, Insomnia, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Laryngitis, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus vulgaris, Lupus-like syndrome, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Oedema, Oedema peripheral, Osteoarthritis, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Prescribed overdose, Prescribed underdose, Pruritus, Psoriasis, Psoriatic arthropathy, Pyrexia, Pulmonary fibrosis, Rash, Red blood cell sedimentation rate increased, Retinitis, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Seronegative arthritis, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to a general medical condition, Spinal fusion surgery, Spondylitis, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Tachycardia, Systemic lupus erythematosus, Type 2 diabetes mellitus, Upper respiratory tract infection, Urticaria, Visual impairment, Vomiting, Walking aid user, Weight decreased, Weight increased, Wheezing, Wound, Wound infection, Dyspnoea, |
||||
ETANERCEPT, ETANERCEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALENDRONATE SODIUM, AZATHIOPRINE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND POLYMYXIN B SULFATE, CALCIUM CARBONATE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CLONIDINE HYDROCHLORIDE, CLONIDINE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE, PREGABALIN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE FUMARATE, QUETIAPINE, SODIUM FLUORIDE, SODIUM FLUORIDE F 18, SODIUM FLUORIDE F-18, TOOTHPASTE, SODIUM FLUORIDE F18, CLEAR MINT, GEL TOOTHPASTE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRICLOSAN, USTEKINUMAB, ERGOCALCIFEROL, |
||||
| 263 | 25101360 |
US |
||
Death, Thrombocytopenia, Neutropenia, Leukopenia, Anaemia, Lymphopenia, Hyperglycaemia, Fatigue, Back pain, Hypocalcaemia, Infusion related reaction, Hypoalbuminaemia, Hyponatraemia, Aspartate aminotransferase increased, Dyspnoea, Headache, Hypophosphataemia, Pyrexia, Pneumonia, Pruritus, Hypertension, Plasma cell myeloma, Encephalopathy, Infection, Sinusitis, Hyperuricaemia, Therapy partial responder, Epistaxis, Chills, Therapy non-responder, Haemorrhage, Diarrhoea, Tachycardia, Nausea, Cough, Wheezing, |
||||
CARFILZOMIB, FILGRASTIM, DARATUMUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BORTEZOMIB FOR INJECTION, BORTEZOMIB, LENALIDOMIDE, POMALIDOMIDE, |
||||
| 264 | 25101485 |
ZA |
85 | |
Biliary tract dilation procedure, Vascular graft, Illness, Infection, |
||||
DAPAGLIFLOZIN, TELMISARTAN, CELECOXIB, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESTRADIOL, BISOPROLOL FUMARATE, |
||||
| 265 | 25101524 |
US |
79 | 2 |
Illness, Acute lymphocytic leukaemia recurrent, Respiratory failure, Cytopenia, Arteriosclerosis coronary artery, Pneumonia, Pneumothorax, Pleural effusion, Infection, |
||||
PREDNISONE, DASATINIB, DASATINIB, DASATINIB, NILOTINIB, BOSUTINIB, BOSUTINIB, METHOTREXATE, METHOTREXATE SODIUM, MERCAPTOPURINE, |
||||
| 266 | 25101644 |
US |
||
Infection, |
||||
C1 ESTERASE INHIBITOR RECOMBINANT, |
||||
| 267 | 25101726 |
CR |
28 | 2 |
CSF test abnormal, Immune-mediated encephalitis, Cognitive disorder, Infection, |
||||
PEMBROLIZUMAB, |
||||
| 268 | 25101958 |
DE |
||
Graft versus host disease, Infection, Leukaemia recurrent, Drug ineffective for unapproved indication, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, RUXOLITINIB, |
||||
| 269 | 25102005 |
US |
4 | 1 |
Blood HIV RNA increased, Pathogen resistance, Infection, |
||||
CABOTEGRAVIR, |
||||
| 270 | 25102020 |
JP |
2 | |
Duodenal ulcer, Enterocolitis, Fistula, Infection, Hypertension, Proteinuria, Anaemia, Pyrexia, Palmar-plantar erythrodysaesthesia syndrome, Malaise, Diarrhoea, Decreased appetite, |
||||
PEMBROLIZUMAB, PACLITAXEL, BEVACIZUMAB, |
||||
| 271 | 25102029 |
US |
4 | 1 |
Blood HIV RNA increased, Pathogen resistance, Infection, |
||||
CABOTEGRAVIR, |
||||
| 272 | 25102072 |
ES |
1 | |
Infection, |
||||
| 273 | 25102289 |
US |
28 | 1 |
Dehydration, Infection, Colitis, Nausea, Vomiting, Loss of consciousness, Crohn^s disease, |
||||
UPADACITINIB, |
||||
| 274 | 25102399 |
CA |
2 | |
Abdominal discomfort, Dyspnoea, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blister, Condition aggravated, Confusional state, Contraindicated product administered, Contusion, Discomfort, Duodenal ulcer perforation, Fatigue, Folliculitis, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypersensitivity, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, |
||||
APREPITANT, FOSAPREPITANT DIMEGLUMINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROCORTISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, HYDROXYCHLOROQUINE SULFATE, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, |
||||
| 275 | 25104368 |
51 | 2 | |
Infection, |
||||
ETANERCEPT, |
||||
| 276 | 25104477 |
75 | 2 | |
Infection, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 277 | 25104631 |
79 | 2 | |
Infection, Therapy interrupted, |
||||
ABATACEPT, |
||||
| 278 | 25104748 |
65 | 2 | |
Infection, Therapy interrupted, |
||||
UPADACITINIB, |
||||
| 279 | 25104752 |
60 | 2 | |
Infection, Therapy interrupted, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 280 | 25104759 |
65 | 2 | |
Infection, |
||||
GUSELKUMAB, |
||||
| 281 | 25106244 |
83 | 1 | |
Scrotal cellulitis, Infection, Oedema, Cardiac failure, |
||||
EMPAGLIFLOZIN, LINEZOLID, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, |
||||
| 282 | 25092453 |
CA |
||
Infection, Back pain, Muscle spasms, Nasopharyngitis, Headache, Cough, Pruritus, Dyspnoea, Off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 283 | 25092957 |
FR |
48 | 2 |
Constipation, Vomiting, Weight decreased, Infection, Therapy interrupted, Therapy non-responder, |
||||
PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PEMBROLIZUMAB, PEMBROLIZUMAB, CISPLATIN, METHYLPREDNISOLONE, |
||||
| 284 | 25093048 |
US |
||
Infection, Asthenia, |
||||
IVOSIDENIB, |
||||
| 285 | 25093188 |
CA |
2 | |
Liver injury, General symptom, Headache, General physical health deterioration, Infection, Hypoaesthesia, Ill-defined disorder, Hypertension, Helicobacter infection, Hypersensitivity, Hypercholesterolaemia, Impaired healing, Hand deformity, Injury, Glossodynia, Grip strength decreased, Infusion related reaction, Hepatic enzyme increased, Sinusitis, Urticaria, Sleep disorder due to general medical condition, insomnia type, Adjustment disorder with depressed mood, Pemphigus, Wheezing, Psoriatic arthropathy, Joint range of motion decreased, Abdominal pain upper, Subcutaneous drug absorption impaired, Contusion, Psoriasis, Myositis, Pneumonia, Pain in extremity, Systemic lupus erythematosus, Pulmonary fibrosis, Vomiting, Blister, Wound infection, Swelling, Oedema, Rash, Chest pain, Lower respiratory tract infection, Amnesia, Migraine, Back disorder, Pruritus, Stomatitis, Memory impairment, Mobility decreased, Decreased appetite, Rheumatic fever, Muscle injury, X-ray abnormal, Weight increased, Swollen joint count increased, Sleep disorder, Type 2 diabetes mellitus, Synovitis, Breast cancer stage II, Wound, Weight decreased, Malaise, Rheumatoid arthritis, Joint swelling, Irritable bowel syndrome, Rash vesicular, Peripheral swelling, Pericarditis, Pustular psoriasis, Pyrexia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ETANERCEPT, ETANERCEPT, ETANERCEPT, USTEKINUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CAFFEINE CITRATE, CAFFEINE CITRATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, NAPROXEN, NAPROXEN SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM GLUCONATE, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, RAMIPRIL, PHENYLEPHRINE HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LISINOPRIL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, SARILUMAB, QUETIAPINE FUMARATE, QUETIAPINE, VEDOLIZUMAB, VEDOLIZUMAB, LORAZEPAM, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PREDNISONE, SECUKINUMAB, SECUKINUMAB, CALCIUM CARBONATE, INFLIXIMAB, INFLIXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, LANSOPRAZOLE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, VITAMIN C, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN AND CAFFEINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CERTOLIZUMAB PEGOL, ADALIMUMAB, ADALIMUMAB, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERGOCALCIFEROL, ERGOCALCIFEROL, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 286 | 25093958 |
US |
58 | 2 |
Chills, Dyspnoea, Infection, Weight decreased, Off label use, |
||||
NINTEDANIB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 287 | 25094138 |
CA |
97 | 2 |
Abdominal pain upper, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Back disorder, Blister, Blood cholesterol increased, Breast cancer stage II, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Duodenal ulcer perforation, Dyspepsia, Fatigue, Fluid retention, Fibromyalgia, Folliculitis, Gait disturbance, Gastrointestinal disorder, Gait inability, General physical health deterioration, General symptom, Grip strength decreased, Glossodynia, Hand deformity, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Infusion related reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Liver injury, Lower respiratory tract infection, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Myositis, Nasopharyngitis, Nausea, Oedema, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pneumonia, Pruritus, Psoriatic arthropathy, Psoriasis, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rheumatic fever, Rheumatoid factor positive, Rheumatoid arthritis, Sleep disorder, Sinusitis, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Type 2 diabetes mellitus, Systemic lupus erythematosus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound, X-ray abnormal, Wound infection, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, IODINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, VITAMIN C, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, CALCIUM, ERGOCALCIFEROL, LANSOPRAZOLE, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, SULFASALAZINE, FISH OIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, LORAZEPAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, |
||||
| 288 | 25094188 |
CA |
||
Acute respiratory distress syndrome, Cerebrovascular accident, Condition aggravated, Death, Infection, Off label use, |
||||
RITUXIMAB, |
||||
| 289 | 25094197 |
AT |
2 | |
Pneumococcal sepsis, Chronic graft versus host disease oral, Chronic graft versus host disease in liver, Scleroderma-like reaction, Scleroderma, Dry eye, Disease progression, Infection, Rash maculo-papular, Infection, Dyspnoea, Dysphagia, Weight decreased, |
||||
CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, ABACAVIR SULFATE, ABACAVIR, LAMIVUDINE, LAMIVUDINE ORAL, RUXOLITINIB, |
||||
| 290 | 25094302 |
GB |
78 | 2 |
Infection, Flatulence, |
||||
ETANERCEPT, |
||||
| 291 | 25094802 |
US |
||
Vascular device infection, Sepsis, Infection, |
||||
EPLONTERSEN, |
||||
| 292 | 25094845 |
61 | 1 | |
Arthralgia, Groin pain, Pain in extremity, Back pain, Abdominal pain, Constipation, Anaemia, Pleural effusion, Chills, Pyrexia, Tremor, Haemangioma of spleen, Infection, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, MESNA, MESNA INJECTION, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, |
||||
| 293 | 25094900 |
63 | 2 | |
Infection, |
||||
UPADACITINIB, |
||||
| 294 | 25094998 |
CN |
55 | 2 |
Hyperkalaemia, Leukopenia, Thrombocytopenia, Anaemia, Neutropenia, Myelosuppression, Hyperphosphataemia, Hypoalbuminaemia, Hypomagnesaemia, Hypophosphataemia, Infection, Rash, Blood creatinine increased, Product use in unapproved indication, |
||||
CARBOPLATIN, CARBOPLATIN, CISPLATIN, CISPLATIN, BEVACIZUMAB, |
||||
| 295 | 25095315 |
IN |
7 | 1 |
Infection, |
||||
SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE, |
||||
| 296 | 25095393 |
CA |
29 | 2 |
Anal abscess, Impaired healing, Infection, Skin infection, Drug ineffective, |
||||
OMALIZUMAB, PREGABALIN, NADOLOL, RIZATRIPTAN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, VORTIOXETINE, VALPROIC ACID, FREMANEZUMAB-VFRM, |
||||
| 297 | 25095449 |
CA |
2 | |
Liver injury, Hypercholesterolaemia, Memory impairment, Grip strength decreased, Headache, Pain in extremity, Joint swelling, Helicobacter infection, Infection, Hand deformity, Mobility decreased, Nasopharyngitis, Impaired healing, Migraine, Hypersensitivity, Ill-defined disorder, Hepatic enzyme increased, General symptom, Joint range of motion decreased, Musculoskeletal stiffness, Pain, Injury, Glossodynia, Hypertension, Muscle injury, Irritable bowel syndrome, Malaise, Lower respiratory tract infection, Hypoaesthesia, Infusion related reaction, Myositis, Nausea, Oedema, |
||||
DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, CALCIUM CARBONATE, ADALIMUMAB-ADAZ, VITAMIN C, PHENYLEPHRINE HYDROCHLORIDE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, OXYCODONE HYDROCHLORIDE, OXYCODONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PREDNISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, LORAZEPAM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SECUKINUMAB, NAPROXEN, NAPROXEN SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, APREMILAST, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, USTEKINUMAB, USTEKINUMAB, CAFFEINE CITRATE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 298 | 25095567 |
US |
||
Adverse event, Giant cell arteritis, Infection, Therapy cessation, Treatment noncompliance, Therapy non-responder, |
||||
PREDNISONE, TOCILIZUMAB, |
||||
| 299 | 25095659 |
US |
2 | |
Emotional disorder, Depression, Hypoaesthesia, Mobility decreased, Hemiparesis, Infection, Flushing, Herpes zoster, Diarrhoea, Fall, Decreased appetite, Mood swings, Sleep disorder, Gastrointestinal disorder, Alopecia, Influenza, Asthenia, Gait disturbance, Paraesthesia, Fatigue, Balance disorder, Nasopharyngitis, Constipation, Back pain, Vomiting, Confusional state, |
||||
DALFAMPRIDINE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DALFAMPRIDINE, CARVEDILOL, LISINOPRIL, METHYLPREDNISOLONE, ERGOCALCIFEROL, VITAMIN C, VITAMIN C, VITAMIN E, CREAM, VITAMIN E, CREAM, FISH OIL, |
||||
| 300 | 25095730 |
JP |
2 | |
Disseminated intravascular coagulation, Infection, Disorientation, |
||||
LENVATINIB, PEMBROLIZUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28